447 related articles for article (PubMed ID: 31872386)
21. BRCA1 germline mutations may be associated with reduced ovarian reserve.
Wang ET; Pisarska MD; Bresee C; Chen YD; Lester J; Afshar Y; Alexander C; Karlan BY
Fertil Steril; 2014 Dec; 102(6):1723-8. PubMed ID: 25256924
[TBL] [Abstract][Full Text] [Related]
22. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.
Winship AL; Willson C; Hansen KR; Hutt KJ; Hickey M
BMJ Open; 2019 Nov; 9(11):e033810. PubMed ID: 31772111
[TBL] [Abstract][Full Text] [Related]
23. BRCA mutations and reproduction.
Daum H; Peretz T; Laufer N
Fertil Steril; 2018 Jan; 109(1):33-38. PubMed ID: 29307397
[TBL] [Abstract][Full Text] [Related]
24. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
Merlino L; Chiné A; Galli C; Piccioni MG
Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
[TBL] [Abstract][Full Text] [Related]
25. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
26. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
27. Fertility preservation in patients with BRCA mutations or Lynch syndrome.
Corrado G; Marchetti C; Trozzi R; Scambia G; Fagotti A
Int J Gynecol Cancer; 2021 Mar; 31(3):332-338. PubMed ID: 33649002
[TBL] [Abstract][Full Text] [Related]
28. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women.
Volodarsky-Perel A; Cai E; Tulandi T; Son WY; Suarthana E; Buckett W
Reprod Biomed Online; 2020 Feb; 40(2):215-222. PubMed ID: 31953011
[TBL] [Abstract][Full Text] [Related]
29. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
[TBL] [Abstract][Full Text] [Related]
30. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.
Oktay K; Kim JY; Barad D; Babayev SN
J Clin Oncol; 2010 Jan; 28(2):240-4. PubMed ID: 19996028
[TBL] [Abstract][Full Text] [Related]
31. Fertility preservation in BRCA-mutated women: when and how?
Grynberg M; Raad J; Comtet M; Vinolas C; Cédrin-Durnerin I; Sonigo C
Future Oncol; 2018 Feb; 14(5):483-490. PubMed ID: 29327596
[TBL] [Abstract][Full Text] [Related]
32. Fertility preservation in BRCA mutation carriers.
Revelli A; Salvagno F; Delle Piane L; Casano S; Evangelista F; Pittatore G; Razzano A; Marchino GL; Gennarelli G; Benedetto C
Minerva Ginecol; 2016 Oct; 68(5):587-601. PubMed ID: 26997146
[TBL] [Abstract][Full Text] [Related]
33. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
34. Hereditary breast cancer and fertility preservation outcomes.
Arab S; Tulandi T; Buckett W
J Assist Reprod Genet; 2022 May; 39(5):1163-1168. PubMed ID: 35403930
[TBL] [Abstract][Full Text] [Related]
35. Ovarian Aging in Women With BRCA Germline Mutations.
Lin W; Titus S; Moy F; Ginsburg ES; Oktay K
J Clin Endocrinol Metab; 2017 Oct; 102(10):3839-3847. PubMed ID: 28938488
[TBL] [Abstract][Full Text] [Related]
36. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer grade and stage do not affect fertility preservation outcomes.
Wald K; Wang A; Abel MK; Morris J; Letourneau JM; Mok-Lin E; Cedars MI; Rosen MP
J Assist Reprod Genet; 2022 May; 39(5):1155-1161. PubMed ID: 35320444
[TBL] [Abstract][Full Text] [Related]
38. Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer.
Rodriguez-Wallberg KA; Oktay K
Oncologist; 2012; 17(11):1409-17. PubMed ID: 23006497
[TBL] [Abstract][Full Text] [Related]
39. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.
Bercaire LMN; Cavagna M; Donadio NF; Rocha AR; Portela R; Alves VR; Santos TBB; Cavagna F; Dzik A; Gebrim LH; Nahas EAP
JBRA Assist Reprod; 2020 Jul; 24(3):257-264. PubMed ID: 32293820
[TBL] [Abstract][Full Text] [Related]
40. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
Gayete-Lafuente S; Turan V; Oktay KH
J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
